维普中文期刊产品整合服务
17篇 您的检索式:作者名="MOBUS V"
    题名 作者 年代 出处 被引量
1Morphological immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines 显示文摘Mobus V Gerharz C D Press U 1997J Cancer1997,52,1:1
2Estabishment and eharacterization of six new human endometrial adenoenocarcinoma cell显示文摘Mobus V Gerharz CD Mitze M 1993Gynecol Oncol1993,48,:1
3Morphological, immunohistochernical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines显示文摘Mobus V Gerharz C D Pressu 1992Int J Cancer1992,52,:1
4Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines 显示文摘Mobus V Gerharz C D Pressu 1992Int J Cancer1992,52,:1
5Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer 显示文摘Kieback D G Stickeler E Mobus V J 2004Anticancer Res2004,37,6:1
6Tumor cell vaccination for gynecological tumors 显示文摘Mobus V Horm S Stock M 1993Hybridoma1993,12,5:1
7Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative chemotherapy for high-risk primary breast cancer显示文摘Untch M Mobus V Kuhn W 2009J Clin Oncol2009,27,18:1
8Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines 显示文摘Mobus V Gerharz C D Pressu 1992Int J Cancer1992,52,:1
9Inten- sive dose-dense corn- pared with converti- onally scheduled preoperatve chemother- apy for high-risk primary breast cancer显示文摘Untch M Mobus V Kuhn W 2009J Clin Oncol2009,27,18:1
10Phase Ⅲ trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer,intergroup trial of the AGO-Ovar/AIO and EBMT显示文摘 Wandt H Frickhofen N 2007J Clin Oncol2007,25,27:1
11Significance of pathological alpha -fetoproteins levels in the framework of prenatal diagnosis显示文摘Caspet F Mobus V Wellek S 1992Z - Gebrutshilfe - Perinatol1992,196,1:1
12Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer显示文摘Untch M Mobus V Kuhn W 2009J Clin Oncol2009,27,18:1
13Morphological,immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines显示文摘Mobus V Gerharz CD Press U 1992Int J Cancer1992,52,1:1
14Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin 显示文摘MOBUS V J MOLL R GERHARZ C D 1998Int J Cancer1998,77,3:1
15Intensive dosedense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer 显示文摘UNTCH M MOBUS V KUHN W 2009J Clin Oncol2009,27,:1
16Muscarinic receptors in celllines from ovarian carcinoma ; negative correlation with survival ofpatients显示文摘Oppitz M Mobus V Brock S 2002Gynecol Oncol2002,85,1:1
17Phase Ⅲ trial of high- dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT显示文摘Mobus V Wandt H Frickhofen N 2007J Clin Oncol2007,25,27:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费